Department of Orthopedic Surgery, Kitahiroshima Town Toyohira Hospital, Hiroshima, Japan
Commentary
Baclofen an Anaesthetic Therapeutic: A Commentary
Author(s): Kimichi Nakamura*
Baclofen is a y-aminobutyric acid agonist that has been licenced for the treatment of spasticity and is widely used in the treatment of neuropathic pain. This medicine has been shown to be effective in the treatment of trigeminal neuralgia in controlled investigations. Baclofen is a gamma-aminobutyric acid agonist that has been approved for the treatment of spasticity and is commonly used in the treatment of neuropathic pain. In controlled studies, this drug has been demonstrated to be effective in the treatment of trigeminal neuralgia. The most effective use of bachfen as an adjuvant analgesic necessitates a thorough understanding of its pharmacology, side effect profile, and dose guidelines, all of which have proven to be valuable in clinical practise [1]. While baclofen was developed as a more brain penetrant form of GABA (-aminobutyric acid) for the treatment of epilepsy, its high.. Read More»
Journal of Anesthesiology and Pain Research received 835 citations as per Google Scholar report